Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Tuberculosis

Free Subscription Articles published in Emerg Infect Dis Retrieve available abstracts of 57 articles: HTML format

Single Articles

July 2022
1. SHEA J, Smith C, Halse TA, Kohlerschmidt D, et al
   Novel Mycobacterium tuberculosis Complex Genotype Related to M. caprae.
   Emerg Infect Dis. 2022;28:1431-1436.
   PubMed     Abstract available
   
   
   May 2022
2. LE RAY LF, Aubry A, Sougakoff W, Revest M, et al
   atpE Mutation in Mycobacterium tuberculosis Not Always Predictive of Bedaquiline Treatment Failure.
   Emerg Infect Dis. 2022;28:1062-1064.
   PubMed     Abstract available
   
   
   April 2022
3. WINGLEE K, Hill AN, Langer AJ, Self JL, et al
   Decrease in Tuberculosis Cases during COVID-19 Pandemic as Reflected by Outpatient Pharmacy Data, United States, 2020.
   Emerg Infect Dis. 2022;28:820-827.
   PubMed     Abstract available
   
   
   March 2022
4. HASAN T, Nguyen VN, Nguyen HB, Nguyen TA, et al
   Retrospective Cohort Study of Effects of the COVID-19 Pandemic on Tuberculosis Notifications, Vietnam, 2020.
   Emerg Infect Dis. 2022;28:684-692.
   PubMed     Abstract available
   
   
   
5. KHAN A, Phares CR, Phuong HL, Trinh DTK, et al
   Overseas Treatment of Latent Tuberculosis Infection in US-Bound Immigrants.
   Emerg Infect Dis. 2022;28:582-590.
   PubMed     Abstract available
   
   
   
6. NATAPRAWIRA HM, Gafar F, Risan NA, Wulandari DA, et al
   Treatment Outcomes of Childhood Tuberculous Meningitis in a Real-World Retrospective Cohort, Bandung, Indonesia.
   Emerg Infect Dis. 2022;28:660-671.
   PubMed     Abstract available
   
   
   November 2021
7. AUNG HL, Nyunt WW, Fong Y, Biggs PJ, et al
   Genomic Profiling of Mycobacterium tuberculosis Strains, Myanmar.
   Emerg Infect Dis. 2021;27:2847-2855.
   PubMed     Abstract available
   
   
   August 2021
8. PAPAVENTSIS D, Dougas G, Kalkouni O, Karabela S, et al
   Occupational Exposure to Zoonotic Tuberculosis Caused by Mycobacterium caprae, Northern Greece, 2019.
   Emerg Infect Dis. 2021;27:1997-1999.
   PubMed     Abstract available
   
   
   
9. LOUIE JK, Agraz-Lara R, Romo L, Crespin F, et al
   Tuberculosis-Associated Hospitalizations and Deaths after COVID-19 Shelter-In-Place, San Francisco, California, USA.
   Emerg Infect Dis. 2021;27:2227-2229.
   PubMed     Abstract available
   
   
   
10. GHIELMETTI G, Kupca AM, Hanczaruk M, Friedel U, et al
    Mycobacterium microti Infections in Free-Ranging Red Deer (Cervus elaphus).
    Emerg Infect Dis. 2021;27:2025-2032.
    PubMed     Abstract available
    
    
    July 2021
11. SOKO RN, Burke RM, Feasey HRA, Sibande W, et al
    Effects of Coronavirus Disease Pandemic on Tuberculosis Notifications, Malawi.
    Emerg Infect Dis. 2021;27:1831-1839.
    PubMed     Abstract available
    
    
    June 2021
12. TALWAR A, Li R, Langer AJ
    Association between Birth Region and Time to Tuberculosis Diagnosis among Non-US-Born Persons in the United States.
    Emerg Infect Dis. 2021;27:1645-1653.
    PubMed     Abstract available
    
    
    April 2021
13. DE VAL BP, Romero B, Tortola MT, Leon LH, et al
    Polyresistant Mycobacterium bovis Infection in Human and Sympatric Sheep, Spain, 2017-2018.
    Emerg Infect Dis. 2021;27:1241-1243.
    PubMed     Abstract available
    
    
    March 2021
14. MALIK AA, Gandhi NR, Lash TL, Cranmer LM, et al
    Effectiveness of Preventive Therapy for Persons Exposed at Home to Drug-Resistant Tuberculosis, Karachi, Pakistan.
    Emerg Infect Dis. 2021;27:805-812.
    PubMed    
    
    
    
15. LAFLEUR M, Reuter KE, Hall MB, Rasoanaivo HH, et al
    Drug-Resistant Tuberculosis in Pet Ring-Tailed Lemur, Madagascar.
    Emerg Infect Dis. 2021;27:977-979.
    PubMed     Abstract available
    
    
    
16. WALTER KS, Tatara MB, Esther da Silva K, Moreira FMF, et al
    Local and Travel-Associated Transmission of Tuberculosis at Central Western Border of Brazil, 2014-2017.
    Emerg Infect Dis. 2021;27:905-914.
    PubMed     Abstract available
    
    
    
17. NGUYEN HV, Nguyen HB, Nguyen NV, Cobelens F, et al
    Decline of Tuberculosis Burden in Vietnam Measured by Consecutive National Surveys, 2007-2017.
    Emerg Infect Dis. 2021;27:872-879.
    PubMed     Abstract available
    
    
    
18. FAROOQ HZ, Cirillo DM, Hillemann D, Wyllie D, et al
    Limited Capability for Testing Mycobacterium tuberculosis for Susceptibility to New Drugs.
    Emerg Infect Dis. 2021;27:985-987.
    PubMed     Abstract available
    
    
    
19. NONGHANPHITHAK D, Chaiprasert A, Smithtikarn S, Kamolwat P, et al
    Clusters of Drug-Resistant Mycobacterium tuberculosis Detected by Whole-Genome Sequence Analysis of Nationwide Sample, Thailand, 2014-2017.
    Emerg Infect Dis. 2021;27:813-822.
    PubMed     Abstract available
    
    
    
20. CUEVAS LE, Santos VS, Lima SVMA, Kontogianni K, et al
    Systematic Review of Pooling Sputum as an Efficient Method for Xpert MTB/RIF Tuberculosis Testing during the COVID-19 Pandemic.
    Emerg Infect Dis. 2021;27:719-727.
    PubMed     Abstract available
    
    
    
21. ZETOLA NM, Moonan PK, Click E, Oeltmann JE, et al
    Population-Based Geospatial and Molecular Epidemiologic Study of Tuberculosis Transmission Dynamics, Botswana, 2012-2016.
    Emerg Infect Dis. 2021;27:835-844.
    PubMed     Abstract available
    
    
    
22. TAZERART F, Saad J, Niar A, Sahraoui N, et al
    Mycobacterium bovis Pulmonary Tuberculosis, Algeria.
    Emerg Infect Dis. 2021;27:972-974.
    PubMed     Abstract available
    
    
    
23. CHITWOOD MH, Pelissari DM, Marques da Silva GD, Bartholomay P, et al
    Trends in Untreated Tuberculosis in Large Municipalities, Brazil, 2008-2017.
    Emerg Infect Dis. 2021;27:957-960.
    PubMed     Abstract available
    
    
    
24. MILLER MA, Kerr TJ, de Waal CR, Goosen WJ, et al
    Mycobacterium bovis Infection in Free-Ranging African Elephants.
    Emerg Infect Dis. 2021;27:990-992.
    PubMed     Abstract available
    
    
    January 2021
25. LEAVITT SV, Jacobson KR, Ragan EJ, Bor J, et al
    Decentralized Care for Rifampin-Resistant Tuberculosis, Western Cape, South Africa.
    Emerg Infect Dis. 2021;27:728-739.
    PubMed     Abstract available
    
    
    December 2020
26. MANDALAKAS AM, Kay AW, Bacha JM, Devezin T, et al
    Tuberculosis among Children and Adolescents at HIV Treatment Centers in Sub-Saharan Africa.
    Emerg Infect Dis. 2020;26.
    PubMed    
    
    
    November 2020
27. HALEY CA, Macias P, Jasuja S, Jones BA, et al
    Novel 6-Month Treatment for Drug-Resistant Tuberculosis, United States.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available
    
    
    
28. HOPEWELL PC, Reichman LB, Castro KG
    Parallels and Mutual Lessons in Tuberculosis and COVID-19 Transmission, Prevention, and Control.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available
    
    
    September 2020
29. HOMOLKA S, Paulowski L, Andres S, Hillemann D, et al
    Two Pandemics, One Challenge-Leveraging Molecular Test Capacity of Tuberculosis Laboratories for Rapid COVID-19 Case-Finding.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available
    
    
    
30. MIGLIORI GB, Thong PM, Akkerman O, Alffenaar JW, et al
    Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January-April 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available
    
    
    
31. JENKS JD, Garfein RS, Zhu W, Hogarth M, et al
    Latent Tuberculosis Screening Using Electronic Health Record Data.
    Emerg Infect Dis. 2020;26:2285-2287.
    PubMed     Abstract available
    
    
    August 2020
32. LAMB GS, Cruz AT, Camp EA, Javier M, et al
    Tuberculosis in Internationally Displaced Children Resettling in Harris County, Texas, USA, 2010-2015(1).
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available
    
    
    
33. JASPARD M, Butel N, El Helali N, Marigot-Outtandy D, et al
    Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France.
    Emerg Infect Dis. 2020;26:1792-1800.
    PubMed     Abstract available
    
    
    July 2020
34. KWAK N, Hwang SS, Yim JJ
    Effect of COVID-19 on Tuberculosis Notification, South Korea.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available
    
    
    
35. THAM SM, Lim WY, Lee CK, Loh J, et al
    Four Patients with COVID-19 and Tuberculosis, Singapore, April-May 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available
    
    
    
36. YAO Z, Chen J, Wang Q, Liu W, et al
    Three Patients with COVID-19 and Pulmonary Tuberculosis, Wuhan, China, January-February 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available
    
    
    
37. SAAD J, Baron S, Lagier JC, Drancourt M, et al
    Mycobacterium bovis Pulmonary Tuberculosis after Ritual Sheep Sacrifice in Tunisia.
    Emerg Infect Dis. 2020;26:1605-1607.
    PubMed     Abstract available
    
    
    May 2020
38. BAIK Y, Modongo C, Moonan PK, Click ES, et al
    Possible Transmission Mechanisms of Mixed Mycobacterium tuberculosis Infection in High HIV Prevalence Country, Botswana.
    Emerg Infect Dis. 2020;26:953-960.
    PubMed     Abstract available
    
    
    
39. RATHI P, Shringarpure K, Unnikrishnan B, Chadha VK, et al
    Pretreatment Out-of-Pocket Expenses for Presumptive Multidrug-Resistant Tuberculosis Patients, India, 2016-2017.
    Emerg Infect Dis. 2020;26:989-992.
    PubMed     Abstract available
    
    
    
40. HORTON KC, Hoey AL, Beraud G, Corbett EL, et al
    Systematic Review and Meta-Analysis of Sex Differences in Social Contact Patterns and Implications for Tuberculosis Transmission and Control.
    Emerg Infect Dis. 2020;26:910-919.
    PubMed     Abstract available
    
    
    
41. MOONAN PK, Zetola NM, Tobias JL, Basotli J, et al
    A Neighbor-Based Approach to Identify Tuberculosis Exposure, the Kopanyo Study.
    Emerg Infect Dis. 2020;26:1010-1013.
    PubMed     Abstract available
    
    
    April 2020
42. VAN DEN BOOGAARD J, Slump E, Schimmel HJ, van der Hoek W, et al
    High Incidence of Active Tuberculosis in Asylum Seekers from Eritrea and Somalia in the First 5 Years after Arrival in the Netherlands.
    Emerg Infect Dis. 2020;26:675-681.
    PubMed     Abstract available
    
    
    March 2020
43. CAMPBELL JR, Falzon D, Mirzayev F, Jaramillo E, et al
    Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available
    
    
    
44. GETAHUN M, Blumberg HM, Sinshaw W, Diriba G, et al
    Low Prevalence of Mycobacterium bovis in Tuberculosis Patients, Ethiopia.
    Emerg Infect Dis. 2020;26:613-615.
    PubMed     Abstract available
    
    
    
45. ZHANG G, Zhang Y, Zhong D, Meng S, et al
    High Prevalence of and Risk Factors for Latent Tuberculosis Infection among Prisoners, Tianjin, China.
    Emerg Infect Dis. 2020;26:516-522.
    PubMed     Abstract available
    
    
    
46. MERKER M, Nikolaevskaya E, Kohl TA, Molina-Moya B, et al
    Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Beijing Clades, Ukraine, 2015.
    Emerg Infect Dis. 2020;26:481-490.
    PubMed     Abstract available
    
    
    
47. TSANG CA, Langer AJ, Kammerer JS, Navin TR, et al
    US Tuberculosis Rates among Persons Born Outside the United States Compared with Rates in Their Countries of Birth, 2012-2016(1).
    Emerg Infect Dis. 2020;26:533-540.
    PubMed     Abstract available
    
    
    
48. TIBBETTS KK, Ottoson RA, Tsukayama DT
    Public Health Response to Tuberculosis Outbreak among Persons Experiencing Homelessness, Minneapolis, Minnesota, USA, 2017-2018.
    Emerg Infect Dis. 2020;26:420-426.
    PubMed     Abstract available
    
    
    
49. HUANG CC, Chu AL, Becerra MC, Galea JT, et al
    Mycobacterium tuberculosis Beijing Lineage and Risk for Tuberculosis in Child Household Contacts, Peru.
    Emerg Infect Dis. 2020;26:568-578.
    PubMed     Abstract available
    
    
    
50. SHUAIB YA, Khalil EAG, Wieler LH, Schaible UE, et al
    Mycobacterium tuberculosis Complex Lineage 3 as Causative Agent of Pulmonary Tuberculosis, Eastern Sudan(1).
    Emerg Infect Dis. 2020;26:427-436.
    PubMed     Abstract available
    
    
    
51. KERR TJ, Gumbo R, Goosen WJ, Rogers P, et al
    Novel Techniques for Detection of Mycobacterium bovis Infection in a Cheetah.
    Emerg Infect Dis. 2020;26:630-631.
    PubMed     Abstract available
    
    
    
52. POORANSINGH S, Sakhamuri S
    Need for BCG Vaccination to Prevent TB in High-Incidence Countries and Populations.
    Emerg Infect Dis. 2020;26:624-625.
    PubMed     Abstract available
    
    
    November 2019
53. FELLAG M, Saad J, Armstrong N, Chabriere E, et al
    Routine Culture-Resistant Mycobacterium tuberculosis Rescue and Shell-Vial Assay, France.
    Emerg Infect Dis. 2019;25:2131-2133.
    PubMed     Abstract available
    
    
    September 2019
54. SINGH PK, Jain A
    Limited Scope of Shorter Drug Regimen for MDR TB Caused by High Resistance to Fluoroquinolone.
    Emerg Infect Dis. 2019;25:1760-1762.
    PubMed     Abstract available
    
    
    July 2019
55. BRODE SK, Chung H, Campitelli MA, Kwong JC, et al
    Prescribing Patterns for Treatment of Mycobacterium avium Complex and M. xenopi Pulmonary Disease in Ontario, Canada, 2001-2013.
    Emerg Infect Dis. 2019;25.
    PubMed     Abstract available
    
    
    
56. HIGGITT RL, Louis van Schalkwyk O, de Klerk-Lorist LM, Buss PE, et al
    Mycobacterium bovis Infection in African Wild Dogs, Kruger National Park, South Africa.
    Emerg Infect Dis. 2019;25:1425-1427.
    PubMed     Abstract available
    
    
    May 2019
57. LUIS BAL, Diaz-Lomeli P, Gomez-Albarran LP, Martinez-Gamboa A, et al
    Mycobacterium obuense Bacteremia in a Patient with Pneumonia.
    Emerg Infect Dis. 2019;25:1015-1016.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: